Bonke Phathekile
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bonke Phathekile has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Martin Opiyo Onani
Organometallics and Nanomaterials, Department of Chemical Sciences, University of the Western Cape, Bellville, South Africa
2 shared publications - Mervin Meyer
Department of Science, Technology and Innovation/TIA Nanotechnology Platform, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa
2 shared publications - Nicole Remaliah Samantha Sibuyi
DSTI/TIA Nanotechnology Platform, Department of Biotechnology, University of the Western Cape, Bellville, South Africa
2 shared publications Abram Madimabe Madiehe
Department of Science, Technology and Innovation/TIA Nanotechnology Platform, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa
1 shared publication- Abram Madimabe Madiehe
DSTI/TIA Nanotechnology Platform, Department of Biotechnology, University of the Western Cape, Bellville, South Africa
1 shared publication - Darius Riziki Martin
Department of Science, Technology and Innovation/TIA Nanotechnology Platform, Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville, Cape Town 7535, South Africa
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (26) , 38706-38722
Selection of Novel DNA Aptamers against HPV16 Biomarker, E6: An In Silico Approach
HPV16 E6 oncoprotein is a critical driver of cervical cancer, necessitating high-specificity diagnostic and therapeutic agents. This study presents an in silico selection of DNA aptamers targeting the HPV16 E6 oncoprotein through a pipeline of structure-based virtual screening and 250 ns Molecular Dynamics (MD) simulations, performed with GROMACS 2019 and the CHARMM36M. Using AutoDock VinaXB and HADDOCK, eight candidates were evaluated against the F2 RNA benchmark. MM/PBSA calculations identified Apt 9 (−143.76 kcal/mol) as the most potent lead, surpassing the affinity of the F2 control (−142.80 kcal/mol). Apt 8 emerged as a key consensus lead, exhibiting superior structural stability (RMSD 0.23 nm) and the most robust interaction network (11.49 hydrogen bonds). Notably, these leads primarily target critical Histidine residues (His78, His118, and His126) on the E6 protein. These results designate Apt 9 and Apt 8 as high-priority candidates for experimental validation, providing a robust theoretical foundation for novel HPV16-targeted interventions.
- 24 June 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (26) , 38706-38722
Open AccessSelection of Novel DNA Aptamers against HPV16 Biomarker, E6: An In Silico Approach
HPV16 E6 oncoprotein is a critical driver of cervical cancer, necessitating high-specificity diagnostic and therapeutic agents. This study presents an in silico selection of DNA aptamers targeting the HPV16 E6 oncoprotein through a pipeline of structure-based virtual screening and 250 ns Molecular Dynamics (MD) simulations, performed with GROMACS 2019 and the CHARMM36M. Using AutoDock VinaXB and HADDOCK, eight candidates were evaluated against the F2 RNA benchmark. MM/PBSA calculations identified Apt 9 (−143.76 kcal/mol) as the most potent lead, surpassing the affinity of the F2 control (−142.80 kcal/mol). Apt 8 emerged as a key consensus lead, exhibiting superior structural stability (RMSD 0.23 nm) and the most robust interaction network (11.49 hydrogen bonds). Notably, these leads primarily target critical Histidine residues (His78, His118, and His126) on the E6 protein. These results designate Apt 9 and Apt 8 as high-priority candidates for experimental validation, providing a robust theoretical foundation for novel HPV16-targeted interventions.
- Open Access
- 5 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Sustained release and efficacy of Kn2-7-loaded chitosan nanoparticles under low pH conditions
Delivery of antimicrobial peptides to low-pH sites is a significant challenge, and results in reduced treatment efficacy for vaginal infections. Chitosan nanoparticles (CNPs) could be ideal vehicles for drugs to acidic pH environments and sustain their therapeutic effects. CNPs were synthesized using the ionic gelation technique and loaded with Kn2-7 peptide. The CNPs were characterized by dynamic light scattering, Fourier transform infrared spectroscopy, high-resolution transmission and scanning electron microscopes. The stability and antibacterial effects of Kn2-7-loaded CNPs were evaluated at low and normal pH levels. The CNPs had a size distribution of 327–416 nm and a zeta potential of 9.61–23.9 mV. The size distribution (340.2–753.7 nm) and Zeta potential (15.9–67.7 mV) of CNPs changed after loading Kn2-7. The CNPs loading capacity and Kn2-7 entrapment efficiency were 35.6% and 78.3%, respectively. The Kn2-7-CNPs were not stable at low-pH and released Kn2-7 instantly; however, stabilization of Kn2-7-CNPs with poly (acrylic acid) (PAA) and tripolyphosphate (TPP) increased their stability and sustained Kn2-7 release at acidic pH. The Kn2-7-CNPs_1 mg/mL TPP-PAA inhibited the growth of Staphylococcus aureus at pH 3.8 better than the Kn2-7 alone. Therefore, the Kn2-7-CNPs_1mg/mL TPP-PAA could serve as a promising candidate for protecting and delivering drugs in low-pH environments.
- 5 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessSustained release and efficacy of Kn2-7-loaded chitosan nanoparticles under low pH conditions
Delivery of antimicrobial peptides to low-pH sites is a significant challenge, and results in reduced treatment efficacy for vaginal infections. Chitosan nanoparticles (CNPs) could be ideal vehicles for drugs to acidic pH environments and sustain their therapeutic effects. CNPs were synthesized using the ionic gelation technique and loaded with Kn2-7 peptide. The CNPs were characterized by dynamic light scattering, Fourier transform infrared spectroscopy, high-resolution transmission and scanning electron microscopes. The stability and antibacterial effects of Kn2-7-loaded CNPs were evaluated at low and normal pH levels. The CNPs had a size distribution of 327–416 nm and a zeta potential of 9.61–23.9 mV. The size distribution (340.2–753.7 nm) and Zeta potential (15.9–67.7 mV) of CNPs changed after loading Kn2-7. The CNPs loading capacity and Kn2-7 entrapment efficiency were 35.6% and 78.3%, respectively. The Kn2-7-CNPs were not stable at low-pH and released Kn2-7 instantly; however, stabilization of Kn2-7-CNPs with poly (acrylic acid) (PAA) and tripolyphosphate (TPP) increased their stability and sustained Kn2-7 release at acidic pH. The Kn2-7-CNPs_1 mg/mL TPP-PAA inhibited the growth of Staphylococcus aureus at pH 3.8 better than the Kn2-7 alone. Therefore, the Kn2-7-CNPs_1mg/mL TPP-PAA could serve as a promising candidate for protecting and delivering drugs in low-pH environments.